Clinical Trial Update

Category
Continent
From
To
 
REGENXBIO Reports Preclinical Benefits of RGX-202...

REGENXBIO Reports Preclinical Benefits of RGX-202...

Category : Clinical Trial Update 11 July 2025

REGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Mi...
BlueRock announces first patient receives investig...

BlueRock announces first patient receives investig...

Category : Clinical Trial Update 10 July 2025

Overview Bayer AG and BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly...
Zhimeng Biopharma’s KCNQ2/3 Opener Cleared for ALS...

Zhimeng Biopharma’s KCNQ2/3 Opener Cleared for ALS...

Category : Clinical Trial Update 10 July 2025

Overview Shanghai Zhimeng Biopharma, Inc. (""Zhimeng Biopharma""), a clinical...
Mind Lab Pro®'s Cognitive Benefits Confirmed in a...

Mind Lab Pro®'s Cognitive Benefits Confirmed in a...

Category : Clinical Trial Update 8 July 2025

Overview Mind Lab Pro® v4.0, developed by Performance Lab® Group, has again been scientif...
Apogee Therapeutics reports positive Phase 2 resul...

Apogee Therapeutics reports positive Phase 2 resul...

Category : Clinical Trial Update 8 July 2025

Overview The antibody treatment could compete with on-market drugs Dupixent and Ebgylss, while of...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!